- Home
- TS vs ZBH Comparison
TS vs ZBH Comparison
Compare TS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TS | ZBH |
|---|---|---|
| Founded | 2001 | 1927 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 17.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TS | ZBH |
|---|---|---|
| Price | $48.67 | $96.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 19 |
| Target Price | $41.50 | ★ $105.17 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 02-18-2026 | 02-10-2026 |
| Dividend Yield | ★ 3.50% | 1.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.86 | ★ 3.55 |
| Revenue | ★ $11,831,250,000.00 | $8,231,500,000.00 |
| Revenue This Year | N/A | $5.67 |
| Revenue Next Year | $0.38 | $4.13 |
| P/E Ratio | ★ $12.16 | $27.17 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $30.06 | $84.59 |
| 52 Week High | $48.83 | $114.44 |
Technical Indicators
Market Signals| Indicator | TS | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 69.13 | 70.19 |
| Support Level | $46.41 | $90.22 |
| Resistance Level | $48.72 | $97.22 |
| Average True Range (ATR) | 0.94 | 2.58 |
| MACD | 0.16 | 1.21 |
| Stochastic Oscillator | 95.35 | 91.69 |
Price Performance
Historical ComparisonAbout TS Tenaris S.A.
Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the US, Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.